Long Term Safety Study of PRALUENT

Clinical trial NCT03694197 · TERMINATED

Trial details

NCT number: NCT03694197
Sponsor: Regeneron Pharmaceuticals
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Heterozygous Familial Hypercholesterolemia Non-familial Hypercholesterolemia

Start date: 2018-09-28
Primary completion: 2020-04-08
Enrollment: 1389

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.